Literature DB >> 35874508

Effect of daflon-500®, a flavonoid compound on chlorpyriphos-induced oxidative changes in the hypophysis and testes in adult male rats.

Aishat O Olatunji1, Joseph O Ayo2, Mohammed M Suleiman3, Suleiman F Ambali1, Muftau Shittu3, Ganiu J Akorede1, Lukman O Raji4, Jamila A Atata5, Khalid T Biobaku1, Mistura O Azeez6.   

Abstract

Alteration of redox status is one of the molecular pathways commonly associated with pesticide toxicity. Antioxidants, including those obtained from plant phenolics, have been shown to mitigate pesticide-induced cellular injury. The present study was aimed at evaluating the effect of daflon-500 ® , a flavonoid compound on sub-chronic chlorpyriphos-evoked changes in antioxidant and biochemical parameters in the hypophysis and testes of adult male rats. Twenty-five male albino rats were randomly divided into 5 groups of 5 animals each. Group I (DW) received distilled water (2 ml/kg); group II (SO) was dosed with soya oil (2 ml/kg); Group III (DAF) received daflon-500 ® at 1000 mg/kg ~ 1/5th of LD50 (≥ 5000 mg/kg); group IV (CP) was administered chlorpyriphos at 7.74 mg/kg ~ 1/10th of LD50 (77.4 mg/kg) while group V (DAF + CP) was previously treated with daflon-500 ® (1000 mg/kg) and then exposed to CP (7.74 mg/kg), 30 min later. Daily oral regimen administration was done for 60 days after which the animals were sacrificed by cervical venesection after light chloroform anesthesia. The hypophysis and testicular tissues were harvested, and their homogenates were analyzed for malondialdehyde, catalase and superoxide dismutase, and acetylcholinesterase levels. A significant increase in the hypophysis and testicular MDA concentrations, coupled with a decrease in the SOD, CAT, and AChE activities were observed in the CP group. The levels of these oxidative and biochemical parameters were alleviated in the group pretreated with Daflon-500 ® . Results of this study demonstrated that pre-treatment with Daflon-500 ® mitigated CP-induced alterations in oxidative and biochemical parameters apparently due to the antioxidant effect of the flavonoid compound.
© The Author(s) under exclusive licence to Korean Society of Toxicology 2022.

Entities:  

Keywords:  Antioxidants; Chlorpyriphos; Daflon-500; Hypophysis; Oxidative stress; Testes

Year:  2022        PMID: 35874508      PMCID: PMC9247132          DOI: 10.1007/s43188-021-00120-2

Source DB:  PubMed          Journal:  Toxicol Res        ISSN: 1976-8257


  18 in total

1.  A new and rapid colorimetric determination of acetylcholinesterase activity.

Authors:  G L ELLMAN; K D COURTNEY; V ANDRES; R M FEATHER-STONE
Journal:  Biochem Pharmacol       Date:  1961-07       Impact factor: 5.858

2.  Malondialdehyde determination as index of lipid peroxidation.

Authors:  H H Draper; M Hadley
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

3.  Suicidal ideation and occupational pesticide exposure among male farmers.

Authors:  Jaeyoung Kim; Dong-Hoon Shin; Won Jin Lee
Journal:  Environ Res       Date:  2013-11-21       Impact factor: 6.498

4.  Reduction in urinary organophosphate pesticide metabolites in adults after a week-long organic diet.

Authors:  Liza Oates; Marc Cohen; Lesley Braun; Adrian Schembri; Rilka Taskova
Journal:  Environ Res       Date:  2014-04-25       Impact factor: 6.498

Review 5.  Molecular mechanisms behind the biological effects of hesperidin and hesperetin for the prevention of cancer and cardiovascular diseases.

Authors:  Ali Roohbakhsh; Hamideh Parhiz; Fatemeh Soltani; Ramin Rezaee; Mehrdad Iranshahi
Journal:  Life Sci       Date:  2015-01-24       Impact factor: 5.037

6.  Chlorpyrifos inhibits cell proliferation through ERK1/2 phosphorylation in breast cancer cell lines.

Authors:  Clara Ventura; Andrés Venturino; Noelia Miret; Andrea Randi; Elena Rivera; Mariel Núñez; Claudia Cocca
Journal:  Chemosphere       Date:  2014-08-31       Impact factor: 7.086

7.  H2O2 modifies membrane structure and activity of acetylcholinesterase.

Authors:  Elena M Molochkina; Olga M Zorina; Lyudmila D Fatkullina; Alexandre N Goloschapov; Elena B Burlakova
Journal:  Chem Biol Interact       Date:  2005-12-15       Impact factor: 5.192

Review 8.  Clinical benefits of Daflon 500 mg in the most severe stages of chronic venous insufficiency.

Authors:  A A Ramelet
Journal:  Angiology       Date:  2001-08       Impact factor: 3.619

9.  Evaluation of clinical activity and safety of Daflon 500 mg in type 2 diabetic female patients.

Authors:  Sherine Maher Rizk; Nagwa Ali Sabri
Journal:  Saudi Pharm J       Date:  2009-08-07       Impact factor: 4.330

Review 10.  Dietary flavonoids: bioavailability, metabolic effects, and safety.

Authors:  Julie A Ross; Christine M Kasum
Journal:  Annu Rev Nutr       Date:  2002-01-04       Impact factor: 11.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.